VISIINC PLC Announces Installations of VISI-MMRPro Systems in Burkhart Dental Offices

LOS ANGELES, CA and PERTH, AUSTRALIA--(Marketwire - Dec 20, 2012) -  MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") and VISIINC PLC ("VISI") jointly announced today that bundled VISI-MMRPro systems are in the process of being shipped and installed to Burkhart Dental. Burkhart is the first major account to install the VISI-MMRPro bundled solution, which is being sold through its network of more than 24,000 dental practice clients across the U.S. VISI-MMRPro is being sold by VISIINC under the terms of an exclusive multi-year distribution agreement between VISI and MMRGlobal for delivery to dental offices. The first deliveries under the agreement called for 25 systems to be shipped in the quarter ended September 30, 2012. VISI-MMRPro is a powerful new bundled solution comprised of hardware and software that can scan and digitize medical records and images in a dental office for storage and sharing. The system also acts as a gateway to synchronize paper-based records into any Electronic Medical Records system. The announcement follows MMRGlobal's filings in its third quarter financial statements that MMR and VISIINC had entered into the agreement to sell 1,275 patented MMRPro systems.

Burkhart Dental is the first major account to install the VISI-MMRPro solution, which is also being offered through a network of Value-Added Resellers, throughout the U.S. While VISI-MMRPro is being sold under an exclusive license to VISIINC for the dental market, it is universally applicable and available for sale by VISIINC to other vertical markets worldwide. 

The VISI-MMRPro system is a part of a bundled solution which also includes the next generation of MMRPro. The system will scan and digitize any kind of information, with the option of writing it locally to the Seagate NASBox as well as the cloud to archive and or share electronically.

MMRGlobal is the owner of five currently issued United States patents and others that are issued, pending and/or applied for in at least 12 countries around the world, including Australia. The patents are related, in general, to VISI-MMRPro and its ability to provision Personal Health Records and Electronic Health Records. The patents include U.S. Patent Nos. 8,121,855; 8,117,646; 8,117,045; 8,301,466 and 8,321,240. MMR also has numerous additional patent applications pending related to patient information and Personal Health Records. Recent activity in health information technology evidences the significant awareness, interest and value in health IT patents which should increase as the industry approaches Stage 2 Meaningful Use requirements in 2014 and continues to mature. The Company believes that its existing patents will give it an advantage for eligible healthcare professionals to fully qualify for incentives under the HITECH Act.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (www.mymedicalrecords.com), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

About VISINC PLC
VisiInc is an emerging leader in facilitating secure collaboration between all Internet-connected devices. VisiInc (Visi) is now launching the next evolution in fully secure Collective Intelligence Management, audio-visual communication, real time instant file and information sharing and advanced collaboration capable of delivering solutions in both physical and virtual environments. VisiInc PLC is a leading software company with development and marketing offices located in the USA. Headquartered in Perth, Australia and registered in the UK. For more information visit www.visiinc.com and www.vistime.com

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature, including but not limited to agreements with VISIINC PLC, the VISI-MMRPro system and Burkhart Dental installs, and the Company's future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "potential," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; product integration in dental practices, physician practices, surgery centers, hospitals and other healthcare facilities; timing and volume of sales and installations; VISIINC's installs of VISI-MMRPro at Burkhart Dental offices; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations, both in the U.S. and internationally; future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry, both in the U.S. and internationally; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company's marketing and promotional campaigns; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, monetize and protect our patent portfolio for both the Company's health IT and biotechnology intellectual property assets in the U.S. and internationally; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.